CXCL12 and ovarian carcinoma: A recent study demonstrated that all 289 ovarian cancer patients analyzed expressed CXCL12, and the rate of CXCR4 expression was 69%; thus CXCL12 can serve as an independent prognostic indicator for ovarian cancer (15).